Products for Research Use Only
RegisterLogin

TRK-IN-32

CAT: 0804-HY-175302Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-175302Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
TRK-IN-32 is a potent TRK inhibitor. TRK-IN-32 potently inhibits TRKWT, TRKG595R and TRKG667C with IC50 values of 0.08 nM, 2.14 nM and 0.68 nM, respectively. TRK-IN-32 also demonstrates antiproliferative activity against a panel of Ba/F3 cell lines transformed with wild type, xDFG, solvent-front as well as gatekeeper mutant TRK fusion proteins. TRK-IN-32 induces apoptosis of Ba/F3-TRKAWT and Ba/F3-TRKAG667C cells.TRK-IN-32 can be used for the study of various cancers (such as thyroid cancer, secretory breast carcinoma) [1].
CAS Number
3044124-79-7
UNSPSC
12352005
Target
Apoptosis; Trk Receptor
Related Pathways
Apoptosis; Neuronal Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
C[C@@H](C1=CC=C(C=N1)F)NC2=NN3C(C4=NNC(C5CC5)=C4)=CN=C3C=C2
Molecular Formula
C19H18FN7
Molecular Weight
363.39
References & Citations
[1]Xu Y, et al. Discovery of imidazo[1,2-b]pyridazine derivatives as potent TRK inhibitors for overcoming multiple resistant mutants. Bioorg Chem. 2025 Aug;163:108737.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-144451TRK-IN-12
HY-146519TRK-IN-14
HY-160166TRK-IN-26
HY-146521TRK-IN-15
HY-12327Trk-IN-1
HY-144423Trk-IN-10
HY-160165TRK-IN-25
HY-161179TRK-IN-27
HY-161819TRK-IN-29
HY-146522TRK-IN-16

Alternative Products

CatalogName
T212244-01TRK-IN-32
PA1321-STrk-A
338192-01Trk A
GTR18303659Trk Antibody
T211064-01TRK-IN-31
T210169-01TRK-IN-29
T209555-01TRK-IN-22
T87568-01TRK-IN-25
T63346-01TRK-IN-18
T62561-01TRK-IN-17

Popular Products